Trial Profile
Cost-Effectiveness Analysis of a "Just-In-Time" Strategy of Salvage Plerixafor Administration for Poor-Mobilizing Patients Undergoing Autologous Transplant.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Feb 2011
Price :
$35
*
At a glance
- Drugs Plerixafor (Primary) ; Granulocyte colony-stimulating factors
- Indications Lymphoma; Multiple myeloma
- Focus Therapeutic Use
- 21 Feb 2011 New trial record